Cancer Research Technology Ltd.

CRT is the technology transfer arm of Cancer Research UK, the largest cancer charity in the UK and the biggest single funding body for cancer research projects in Europe. The organization's primary remit is commercializing the IP generated by the £175 million ($274 million) of research funding that Cancer Research UK provides each year.

Cancer Research Technology (CRT) stands out as one of the world's largest specialist technology transfer organizations. Focusing commercialization activities on one therapeutic area is in itself unusual compared with most European and US tech transfer operations, which tend to cover entire, often multi-disciplinary universities or research institutes. But additional aspects of CRT's model—its own in-house development capabilities and its capacity to package intellectual property (IP) from research conducted around the world—combine to offer what CRT claims is a unique approach to technology transfer.

CRT is the technology transfer arm of Cancer Research UK, the largest cancer charity in the UK and the biggest...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Global Vision

More from In Vivo